Dynasil Signs Technology Collaboration Agreement with Mayo Clinic

Dynasil Corporation of America DYSL today announced that it has entered into a technology collaboration agreement with Mayo Clinic, a not-for-profit worldwide leader in medical care, research and education for people from all walks of life. The first project under the collaborative agreement will focus on the development of a therapeutic hypothermia core cooling technology designed to protect the brain during cardiac arrest and traumatic brain injury. Separately, Dynasil and Mayo Clinic are working together on a blood storage technology designed to extend the shelf life of blood products. The collaboration agreement addresses issues such as reimbursement for development costs as well as the role each party will play in patent protection and commercialization. It broadens a relationship that began in 2011, when Dynasil acquired a biomedical technology portfolio from hematologist Dr. Daniel Ericson. The portfolio included several discoveries owned jointly by Dr. Ericson and Mayo Clinic.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContractsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!